A long non-coding RNA inside the type 2 transglutaminase gene tightly correlates with the expression of its transcriptional variants

[1]  M. Piacentini,et al.  Transglutaminase 2, a double face enzyme , 2017, Amino Acids.

[2]  U. A. Ørom,et al.  Enhancer RNAs , 2017, Methods in Molecular Biology.

[3]  I. Samudio,et al.  All Trans Retinoic Acid, Transforming Growth Factor β and Prostaglandin E2 in Mouse Plasma Synergize with Basophil-Secreted Interleukin-4 to M2 Polarize Murine Macrophages , 2016, PloS one.

[4]  Marcel E Dinger,et al.  Computational Approaches for Functional Prediction and Characterisation of Long Noncoding RNAs. , 2016, Trends in genetics : TIG.

[5]  Z. Szondy,et al.  FOR THE DEGREE OF DOCTOR OF PHILOSOPHY ( P H D ) TRANSCRIPTIONAL CONTROL OF TRANSGLUTAMINASE 2 EXPRESSION IN MOUSE APOPTOTIC THYMOCYTES , 2016 .

[6]  S. Kojima,et al.  Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death , 2016, Cell Death and Disease.

[7]  N. Imamoto,et al.  Molecular mechanism by which acyclic retinoid induces nuclear localization of transglutaminase 2 in human hepatocellular carcinoma cells , 2015, Cell Death and Disease.

[8]  C. Kerr,et al.  Transglutaminase is a tumor cell and cancer stem cell survival factor , 2015, Molecular carcinogenesis.

[9]  Satyanarayan Rao,et al.  Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets , 2015, Molecular and Cellular Therapies.

[10]  Sara A. Grimm,et al.  GATA3 in Breast Cancer: Tumor Suppressor or Oncogene? , 2015, Gene expression.

[11]  Yun‐Sil Lee,et al.  Transglutaminase II/MicroRNA-218/-181a Loop Regulates Positive Feedback Relationship between Allergic Inflammation and Tumor Metastasis* , 2014, The Journal of Biological Chemistry.

[12]  R. Evans,et al.  The active enhancer network operated by liganded RXR supports angiogenic activity in macrophages , 2014, Genes & development.

[13]  C. Glass,et al.  Enhancer RNAs and regulated transcriptional programs. , 2014, Trends in biochemical sciences.

[14]  R. Eckert,et al.  Transglutaminase regulation of cell function. , 2014, Physiological reviews.

[15]  Hyun-Jung Byun,et al.  12-O-Tetradecanoylphorbol-13-Acetate Induces Keratin 8 Phosphorylation and Reorganization via Expression of Transglutaminase-2 , 2014, Biomolecules & therapeutics.

[16]  J. Nielsen,et al.  Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics. , 2014, Molecular & cellular proteomics : MCP.

[17]  O. Ohara,et al.  Ubiquitin‐specific protease 2‐69 in macrophages potentially modulates metainflammation , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  S. Gordon,et al.  Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences. , 2013, Blood.

[19]  R. Elkon,et al.  eRNAs are required for p53-dependent enhancer activity and gene transcription. , 2013, Molecular cell.

[20]  Jie Wang,et al.  Factorbook.org: a Wiki-based database for transcription factor-binding data generated by the ENCODE consortium , 2012, Nucleic Acids Res..

[21]  C. Greenberg,et al.  TGM2 and implications for human disease: role of alternative splicing. , 2013, Frontiers in bioscience.

[22]  K. Mehta,et al.  Tissue Transglutaminase Constitutively Activates HIF-1α Promoter and Nuclear Factor-κB via a Non-Canonical Pathway , 2012, PloS one.

[23]  K. Coombes,et al.  PKCδ Regulates Translation Initiation through PKR and eIF2α in Response to Retinoic Acid in Acute Myeloid Leukemia Cells , 2012, Leukemia research and treatment.

[24]  Fabian A. Buske,et al.  Triplexator: Detecting nucleic acid triple helices in genomic and transcriptomic data , 2012, Genome research.

[25]  J. Jeon,et al.  Doxorubicin induces the persistent activation of intracellular transglutaminase 2 that protects from cell death , 2012, Molecules and cells.

[26]  S. Kojima,et al.  New insights into the functions and localization of nuclear transglutaminase 2 , 2011, The FEBS journal.

[27]  L. Fésüs,et al.  Protein transamidation by transglutaminase 2 in cells: a disputed Ca2+‐dependent action of a multifunctional protein , 2011, The FEBS journal.

[28]  C. Bergamini,et al.  Structure and regulation of type 2 transglutaminase in relation to its physiological functions and pathological roles. , 2011, Advances in enzymology and related areas of molecular biology.

[29]  C. Glass,et al.  Reprogramming Transcription via Distinct Classes of Enhancers Functionally Defined by eRNA , 2011, Nature.

[30]  A. Tanay,et al.  Dynamic combinatorial interactions of RUNX1 and cooperating partners regulates megakaryocytic differentiation in cell line models. , 2011, Blood.

[31]  D. C. Hughes,et al.  Expression of transglutaminase-2 isoforms in normal human tissues and cancer cell lines: dysregulation of alternative splicing in cancer , 2011, Amino Acids.

[32]  E. Barta,et al.  Polymorphism of transglutaminase 2: unusually low frequency of genomic variants with deficient functions , 2011, Amino Acids.

[33]  B. Blencowe,et al.  The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. , 2010, Molecular cell.

[34]  Kevin Cook,et al.  TCR-Dependent Translational Control of GATA-3 Enhances Th2 Differentiation , 2010, The Journal of Immunology.

[35]  L. Sollid,et al.  Redox Regulation of Transglutaminase 2 Activity* , 2010, The Journal of Biological Chemistry.

[36]  A. Verma,et al.  Tissue transglutaminase promotes or suppresses tumors depending on cell context. , 2009, Anticancer research.

[37]  Jacek Majewski,et al.  Gene Expression and Isoform Variation Analysis using Affymetrix Exon Arrays , 2008, BMC Genomics.

[38]  Mark D. Robinson,et al.  FIRMA: a method for detection of alternative splicing from exon array data , 2008, Bioinform..

[39]  X. Yao,et al.  Hepatic insulin resistance induced by prenatal alcohol exposure is associated with reduced PTEN and TRB3 acetylation in adult rat offspring. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[40]  James H. Bullard,et al.  aroma.affymetrix: A generic framework in R for analyzing small to very large Affymetrix data sets in bounded memory , 2008 .

[41]  P. Hasselgren.  Ubiquitination, phosphorylation, and acetylation—triple threat in muscle wasting , 2007, Journal of cellular physiology.

[42]  G. Perini,et al.  Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis , 2007, Proceedings of the National Academy of Sciences.

[43]  Nathaniel D. Heintzman,et al.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome , 2007, Nature Genetics.

[44]  Ana Serra Barros,et al.  Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript , 2007, Nature.

[45]  N. Colburn,et al.  Programmed Cell Death-4 Tumor Suppressor Protein Contributes to Retinoic Acid–Induced Terminal Granulocytic Differentiation of Human Myeloid Leukemia Cells , 2007, Molecular Cancer Research.

[46]  D. Spector,et al.  Eukaryotic regulatory RNAs: an answer to the 'genome complexity' conundrum. , 2007, Genes & development.

[47]  John N. Hutchinson,et al.  A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains , 2007, BMC Genomics.

[48]  Douglas D. Boyd,et al.  Histone H3 Acetylation and H3 K4 Methylation Define Distinct Chromatin Regions Permissive for Transgene Expression , 2006, Molecular and Cellular Biology.

[49]  B. Aggarwal,et al.  Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway. , 2006, Cancer research.

[50]  Jan Barciszewski,et al.  A new frontier for molecular medicine: noncoding RNAs. , 2005, Biochimica et biophysica acta.

[51]  F. Costa,et al.  Non-coding RNAs: new players in eukaryotic biology. , 2005, Gene.

[52]  A. Sahin,et al.  Prognostic Significance of Tissue Transglutaminase in Drug Resistant and Metastatic Breast Cancer , 2004, Clinical Cancer Research.

[53]  T. Joh,et al.  Transglutaminase 2 induces NF-κB activation via a novel pathway in BV-2 microglia , 2004 .

[54]  J. Mattick.  RNA regulation: a new genetics? , 2004, Nature Reviews Genetics.

[55]  K. Bhakat,et al.  Role of acetylated human AP‐endonuclease (APE1/Ref‐1) in regulation of the parathyroid hormone gene , 2003, The EMBO journal.

[56]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[57]  H. Choy,et al.  Histone cross-linking by transglutaminase. , 2002, Biochemical and biophysical research communications.

[58]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[59]  M. Fabbi,et al.  Late apoptotic effects of taxanes on K562 erythroleukemia cells: apoptosis is delayed upstream of caspase-3 activation. , 2000, International journal of cancer.

[60]  D. Price,et al.  Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[61]  G. Johnson,et al.  Modulation of the in Situ Activity of Tissue Transglutaminase by Calcium and GTP* , 1998, The Journal of Biological Chemistry.

[62]  P. Davies,et al.  Regulation of the expression of the tissue transglutaminase gene by DNA methylation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[63]  M. Zern,et al.  A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-kappaB. , 1997, The American journal of physiology.

[64]  R. Gonzales,et al.  A third human tissue transglutaminase homologue as a result of alternative gene transcripts. , 1996, Biochimica et biophysica acta.

[65]  K. N. Lee,et al.  Differential expression of transglutaminase in human erythroleukemia cells in response to retinoic acid. , 1990, Cancer research.

[66]  S. Collins,et al.  Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. , 1980, Proceedings of the National Academy of Sciences of the United States of America.